Assertio Therapeutics and Purdue Pharma Settle Patent Infringement Lawsuit
Under the terms of the agreement, Purdue will pay Assertio a total of
“We are extremely pleased to settle this litigation with Purdue in a manner that is favorable to the Company and to our shareholders,” said
INVESTOR AND MEDIA CONTACT:
SVP, Investor Relations and Corporate Communications
Source: Assertio Therapeutics, Inc.
Minimum 15 minutes delayed.